Gossamer Bio, Inc. ( GOSS) - Key Metrics
GOSS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.06 | -$0.21 | -$0.21 | -$0.21 |
| 2025Q3 | $0.06 | -$0.21 | -$0.16 | -$0.16 |
| 2025Q2 | $0.05 | -$0.17 | -$0.21 | -$0.21 |
| 2025Q1 | $0.04 | -$0.16 | -$0.18 | -$0.18 |
GOSS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -3.72 |
| 2025Q3 | ? | -3.11 |
| 2025Q2 | ? | -1.83 |
| 2025Q1 | ? | -1.70 |
GOSS
Price: $0.17
52 week price:
Earnings Per Share: -0.79 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 916653
Market Capitalization: 44.5 million